Reishi (Ganoderma lucidum), long revered as the “herb of immortality” in traditional Chinese medicine, has been widely valued for its health-promoting and longevity-supporting properties. Modern scientific research is increasingly validating these traditional claims. A recent study published in Nature Communications by researchers from Tongji Medical College of Huazhong University of Science and Technology identified ganoderic acid A, a major active compound in reishi, as a promising senotherapeutic agent. Through high-content screening of 805 natural compounds, the researchers demonstrated that ganoderic acid A can significantly reduce cellular senescence markers and extend lifespan in multiple experimental models. Beyond its anti-aging effects, ganoderic acid A has also been reported to exhibit hepatoprotective, lipid-regulating, and neuroprotective activities. These findings provide strong scientific support for the modern applications of reishi-derived compounds in functional foods, dietary supplements, and health products.
The Anti-Aging Potential of Ganoderic Acid A
Since ancient times, reishi (Ganoderma lucidum) has been honored as a “miraculous herb” and holds an important place in traditional Chinese medicine. It has long been regarded as a precious medicinal material capable of promoting longevity and strengthening the body’s vital energy. This ancient herb not only carries a rich cultural heritage, but its health benefits are also increasingly supported by modern scientific evidence.
A research team from Tongji Medical College of Huazhong University of Science and Technology published findings in the journal Nature Communications, demonstrating that ganoderic acid A, a major active compound found in reishi, exhibits significant anti-aging effects. This discovery provides strong scientific support for the modern medicinal value of reishi.
Ganoderic Acid A Extends Lifespan and Promotes Healthy Aging
Cellular senescence plays a key role in organismal aging and the development of age-related diseases. It is characterized by permanent cell cycle arrest, enhanced resistance to apoptosis, and the secretion of senescence-associated secretory phenotype (SASP) factors.
The research team screened 805 potential anti-aging natural compounds and identified ganoderic acid A as a promising candidate. Within a concentration range of 0.1–1000 μM, ganoderic acid A exhibited low cytotoxicity and significantly reduced the proportion of SA-β-Gal-positive senescent cells.
The team further validated its effects using ten cellular senescence models derived from mice, rats, and humans, confirming the broad anti-aging activity of ganoderic acid A. The compound reduced SA-β-Gal-positive cells by 5%–65%, decreased lactate dehydrogenase (LDH) release by 9%–34%, and significantly promoted cell proliferation while reducing the enlarged nuclear area typical of senescent cells.
Animal experiments showed that ganoderic acid A could extend the lifespan of Caenorhabditis elegans in a dose-dependent manner. At a concentration of 1000 μM, the maximum lifespan of the worms increased by 26%, an effect comparable to the well-known anti-aging drug rapamycin. In addition, ganoderic acid A reduced lipofuscin accumulation, reactive oxygen species (ROS) levels, and lipid deposition in the worms, while improving locomotion, body bending, and pharyngeal pumping ability, thereby extending healthspan.
The team also conducted experiments using three classic mouse models of aging-related conditions, obtaining the following important findings:
1. Radiation-induced premature aging model
Ganoderic acid A significantly alleviated pathological damage in the spleen and testes, reduced the accumulation of SA-β-Gal-positive cells in multiple organs such as the heart, liver, kidney, and lungs, and effectively lowered the expression levels of aging markers.
2. Naturally aged mouse model
Ganoderic acid A significantly extended the lifespan of elderly mice, which is equivalent to extending human lifespan by more than one year at the age of 69. In addition, the compound markedly reduced the expression of aging markers in multiple organs, alleviated pathological organ damage, increased levels of the anti-aging protein klotho by 37%, and improved the mice’s motor capacity by 70%.
3. Western-diet-induced obese mouse model
Ganoderic acid A reduced the accumulation of senescent cells in multiple organs, alleviated organ fibrosis, lowered blood lipid levels, improved glucose and lipid metabolism as well as insulin resistance, and helped restore muscle mass and bone microstructure, thereby improving overall physiological function in mice.
These results demonstrate that ganoderic acid A exhibits significant protective and anti-aging potential across multiple aging-related models.
Ganoderic acid A (GAA) treatment extends the healthspan of aged mice
Beyond Longevity: Diverse Health Benefits of Ganoderic Acid A
Reishi contains more than 400 natural bioactive compounds, including triterpenoids, polysaccharides, nucleosides, and other components. Among them, triterpenoids exceed 300 types and represent the key material basis underlying the health benefits of reishi.
Ganoderic acid A, one of the most abundant triterpenoids in reishi, is widely present in Ganoderma species. Its chemical structure is a highly oxidized lanostane derivative, and this unique molecular structure contributes to its high value for pharmacological research.
Chemical structure of Ganoderic Acid A
In recent years, with the advancement of modern pharmacological research, the health benefits of ganoderic acid A have been increasingly explored. Its potential roles in liver protection, lipid regulation, and neuroprotection have gradually become important research hotspots among natural bioactive compounds.
1. Hepatoprotective Effects
The liver is the central organ responsible for metabolic processes in the human body. Long-term exposure to alcohol, medications, and high-fat diets can easily lead to liver injury, inflammation, and even fibrosis.
Modern pharmacological studies have confirmed that ganoderic acid A exhibits significant protective effects against liver injury induced by multiple factors.
For example, ganoderic acid A can significantly inhibit endoplasmic reticulum stress, thereby improving liver inflammation and fibrosis and counteracting non-alcoholic fatty liver disease induced by high-fat and high-cholesterol diets.
2. Lipid-Lowering Effects
Disorders of lipid metabolism are key drivers of hyperlipidemia, obesity, insulin resistance, cardiovascular diseases, and hepatic steatosis.
Sterol regulatory element-binding proteins (SREBPs) are key transcription factors that regulate the biosynthesis and gene expression of cholesterol, fatty acids, and triglycerides.
Both in vivo and in vitro experiments have demonstrated that ganoderic acid A can precisely regulate the expression of SREBP target genes, effectively reducing excessive accumulation of cholesterol and triglycerides in the body. It also improves diet-induced obesity in animals and enhances insulin sensitivity.
3. Neuroprotective Effects
Multiple sclerosis (MS) is an inflammatory autoimmune disease affecting the nervous system and can severely impair motor function.
Studies have shown that ganoderic acid A can bidirectionally regulate neuroimmune responses: it increases the expression of anti-inflammatory markers such as interleukin-4 (IL-4) and brain-derived neurotrophic factor (BDNF) while simultaneously reducing inflammatory cytokines. As a result, it significantly improves motor ability in MS experimental models and alleviates neurological damage.
Alzheimer’s disease (AD) is a common neurodegenerative disorder characterized by memory decline and cognitive impairment. The abnormal accumulation of β-amyloid (Aβ) in the central nervous system is an important pathogenic mechanism.
Research indicates that ganoderic acid A can promote the clearance of β-amyloid and reduce its deposition in the brain, thereby improving cognitive deficits in AD experimental models and providing new insights into natural compound-based strategies for neurodegenerative disease intervention.
Market Applications of Reishi
As a traditional and valuable tonic medicinal material in China, reishi has a long history of application and consistently high market recognition. With the continuous advancement of modern pharmacological research, the mechanisms of core active compounds such as ganoderic acid A have been increasingly clarified while its traditional value remains widely acknowledged.
In particular, the confirmation of multiple pharmacological effects of ganoderic acid A provides strong scientific evidence supporting the development of reishi-based products and promotes the large-scale and standardized application of reishi in foods and health products.
According to data from the China Association of Chinese Medicine, the reishi market reached 21.5 billion RMB in 2023, with a compound annual growth rate of 9.8% over the past five years. Among them, health food products account for 51%, while pharmaceutical-grade products represent 39%.
1. Food Applications
In the food sector, reishi—recognized as a medicine-food homologous ingredient—can be widely incorporated into daily food product development. Various mature product forms have already been developed in the market.
Common examples include reishi tea, reishi beverages, reishi biscuits, and reishi powder.
2. Dietary Supplements
In the dietary supplement sector, the application of reishi is even more mature. Mainstream products include broken-wall reishi spore powder, reishi spore oil, and reishi extract capsules.
These products rely on high-activity bioactive components as their core advantage and are mainly targeted toward individuals with low immunity, frequent fatigue from staying up late, elevated blood lipid levels, or heavy liver burden. Supported by the scientific research on compounds such as ganoderic acid A, these products have a relatively solid evidence base and enjoy strong consumer recognition.
